
PhaseV is a Boston-based technology company that leverages advanced causal machine learning and GenAI, augmented by an expansive data lake and real-world data (RWD), to empower biopharma sponsors and CROs with fast, accurate, and efficient clinical development decisions. The company offers a comprehensive suite of AI-powered solutions that optimize every phase of the clinical trial process, helping clients to rapidly design and implement adaptive and Bayesian clinical trials, analyze data for heterogeneous treatment effects, and improve trial planning. With over 30 biopharma and CRO customers and a commitment to transforming clinical development, PhaseV is positioned to bring new treatments to patients more efficiently.

PhaseV is a Boston-based technology company that leverages advanced causal machine learning and GenAI, augmented by an expansive data lake and real-world data (RWD), to empower biopharma sponsors and CROs with fast, accurate, and efficient clinical development decisions. The company offers a comprehensive suite of AI-powered solutions that optimize every phase of the clinical trial process, helping clients to rapidly design and implement adaptive and Bayesian clinical trials, analyze data for heterogeneous treatment effects, and improve trial planning. With over 30 biopharma and CRO customers and a commitment to transforming clinical development, PhaseV is positioned to bring new treatments to patients more efficiently.
Founded: 2023
Headquarters: Cambridge / Boston, MA
Sector: AI/ML for clinical trial optimization (biopharma/CRO)
Customers: 30–45+ biopharma and CRO customers (company claims)
Funding: Series A on 2025-05-13; total funding reported ~$65M
| Company |
|---|
Clinical trial design and operations optimization, subgroup/heterogeneous treatment effect analysis, adaptive and Bayesian trial implementation.
2023
Pharmaceutical Manufacturing
Seed round participation included Viola Ventures
Series A reported as led by Accel and Insight Partners
“Participation from Accel, Insight Partners, Exor Ventures, Viola Ventures, LionBird”
About PhaseV
PhaseV is a Boston-based technology company that redefines clinical development at scale with its enterprise-ready, multi-modal AI/ML platform — accelerating decisions, de-risking trials, and driving more efficient portfolio strategies. With over $65M raised from Accel, Insight, and others, we are poised to make a significant impact on how drugs are developed and brought to market.
Trusted by 45+ pharmaceutical sponsors and CROs, our causal AI technology identifies responder subgroups with greater precision, optimizes trial designs, life cycle management, site selection, and monitors trial performance in real-time to help bring treatments to patients faster.
The Role
We're hiring our first dedicated marketer to lead our marketing strategy in support of our continued growth. This is a rare opportunity to continue to architect our brand presence and dramatically expand PhaseV’s share of voice
You will report to the Head of Strategy and Transformation, and work directly with the PhaseV leadership team to implement marketing strategies that build our sales pipeline, enable our sales team, and generate the target ROI. This includes refining the PhaseV story and pitch, and establishing PhaseV as the category leader in AI-powered clinical development. This role combines strategic thinking with hands-on execution—you'll set the vision and roll up your sleeves to make it happen in partnership with Business Development, Strategy, and Product.
Please apply here: https://job-boards.greenhouse.io/phasev/jobs/4132111009. Others applications will not be considered. Thank you!
What you'll own
Pipeline & Lead Generation
Brand & Narrative
Events & Conferences
Cross-Functional Leadership
What you bring
Required Experience
Skills & Attributes
Preferred
What we offer
PhaseV is an equal opportunity employer. We celebrate diversity and are committed to creating an inclusive environment for all employees.